Vaccine trial in Guinea-Bissau prompts widespread ethical objections
A trial led by Danish researchers involving about 14,000 children in Guinea-Bissau has prompted objections because half of the participants will not receive the hepatitis B vaccine at birth. Four members of a research ethics committee resigned, while doctors and academics warned of the virus’s known risks to infants.
